|
CN1119344C
(zh)
|
1996-12-19 |
2003-08-27 |
阿旺蒂斯制药公司 |
杂环取代的新型吡咯烷酰胺衍生物
|
|
KR100591585B1
(ko)
|
1999-08-31 |
2006-06-20 |
깃세이 야쿠힌 고교 가부시키가이샤 |
글루코피라노실옥시피라졸 유도체, 그것을 함유하는 의약조성물 및 그 제조 중간체
|
|
MXPA02003254A
(es)
|
1999-09-27 |
2002-09-30 |
Pioneer Hi Bred Int |
Tolerancia mejorada al estres en maiz via manipulacion de los genes reguladores del ciclo de la celula.
|
|
US6515117B2
(en)
|
1999-10-12 |
2003-02-04 |
Bristol-Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
|
PH12000002657B1
(en)
|
1999-10-12 |
2006-02-21 |
Bristol Myers Squibb Co |
C-aryl glucoside SGLT2 inhibitors
|
|
EP1344780A4
(en)
|
2000-11-30 |
2004-01-28 |
Kissei Pharmaceutical |
GLUCOPYRANOSYLOXYBENZYLBENZOLE DERIVATIVES, MEDICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION
|
|
ATE431830T1
(de)
|
2000-12-28 |
2009-06-15 |
Kissei Pharmaceutical |
Glucopyranosylpyrazolderivate und deren verwendung in arzneimitteln
|
|
MXPA04009229A
(es)
|
2002-03-22 |
2004-11-26 |
Kissei Pharmaceutical |
Cristales derivados de glucopiranosiloxibencil benceno.
|
|
DE10231370B4
(de)
|
2002-07-11 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
|
JP4580866B2
(ja)
|
2002-12-19 |
2010-11-17 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ｔａｃｅのインヒビター
|
|
JP2006518381A
(ja)
|
2003-02-07 |
2006-08-10 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼのインヒビターとして有用なヘテロアリール置換ピロール
|
|
ES2363941T3
(es)
|
2003-03-14 |
2011-08-19 |
Astellas Pharma Inc. |
Derivados de c-glucósido para el tratamiento de diabetes.
|
|
ES2531660T3
(es)
|
2003-08-01 |
2015-03-18 |
Mitsubishi Tanabe Pharma Corporation |
Compuestos novedosos que tienen actividad inhibidora frente a transportador de glucosa dependiente de sodio
|
|
EP1663204B1
(en)
|
2003-08-29 |
2014-05-07 |
Exelixis, Inc. |
C-kit modulators and methods of use
|
|
CN103030617A
(zh)
|
2004-03-16 |
2013-04-10 |
贝林格尔.英格海姆国际有限公司 |
吡喃葡萄糖基取代的苯基衍生物、含该化合物的药物、其用途及其制造方法
|
|
WO2006028269A2
(en)
|
2004-09-09 |
2006-03-16 |
Astellas Pharma Inc. |
Thiazole derivatives having vap-1 ihibitory activity
|
|
TW200637839A
(en)
|
2005-01-07 |
2006-11-01 |
Taisho Pharmaceutical Co Ltd |
1-thio-d-glucitol derivatives
|
|
TW200637869A
(en)
|
2005-01-28 |
2006-11-01 |
Chugai Pharmaceutical Co Ltd |
The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
|
|
UA91546C2
(uk)
|
2005-05-03 |
2010-08-10 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
|
|
US7772191B2
(en)
|
2005-05-10 |
2010-08-10 |
Boehringer Ingelheim International Gmbh |
Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
|
|
US7989622B2
(en)
|
2005-10-07 |
2011-08-02 |
Exelixis, Inc. |
Phosphatidylinositol 3-kinase inhibitors and methods of their use
|
|
AR059489A1
(es)
|
2006-02-15 |
2008-04-09 |
Boehringer Ingelheim Vetmed |
Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
|
|
US20070293548A1
(en)
|
2006-03-31 |
2007-12-20 |
Wang Eric Y |
Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases
|
|
US7803778B2
(en)
|
2006-05-23 |
2010-09-28 |
Theracos, Inc. |
Glucose transport inhibitors and methods of use
|
|
US7919598B2
(en)
|
2006-06-28 |
2011-04-05 |
Bristol-Myers Squibb Company |
Crystal structures of SGLT2 inhibitors and processes for preparing same
|
|
TWI499414B
(zh)
|
2006-09-29 |
2015-09-11 |
Lexicon Pharmaceuticals Inc |
鈉與葡萄糖第２型共同運輸體（ｃｏ-ｔｒａｎｓｐｏｒｔｅｒ ２）的抑制物與其應用方法
|
|
UY30730A1
(es)
|
2006-12-04 |
2008-07-03 |
Mitsubishi Tanabe Pharma Corp |
Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
|
|
WO2008071646A1
(en)
|
2006-12-11 |
2008-06-19 |
Boehringer Ingelheim International Gmbh |
New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds
|
|
TW200904405A
(en)
|
2007-03-22 |
2009-02-01 |
Bristol Myers Squibb Co |
Pharmaceutical formulations containing an SGLT2 inhibitor
|
|
PT2183263E
(pt)
|
2007-07-26 |
2012-01-11 |
Lexicon Pharmaceuticals Inc |
Processos e compostos úteis na preparação de inibidores do co-transportador 2 de glucose e sódio
|
|
US20090054392A1
(en)
|
2007-08-20 |
2009-02-26 |
Wyeth |
Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
|
|
RS56990B1
(sr)
|
2007-09-10 |
2018-05-31 |
Janssen Pharmaceutica Nv |
Postupak za dobijanje jedinjenja koja su korisna kao inhibitori sglt
|
|
TW201011043A
(en)
|
2008-06-20 |
2010-03-16 |
Chugai Pharmaceutical Co Ltd |
Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives
|
|
TWI472521B
(zh)
|
2008-07-17 |
2015-02-11 |
Lexicon Pharmaceuticals Inc |
（２ｓ，３ｒ，４ｒ，５ｓ，６ｒ）－２－（４－氯－３－（４－乙氧苄基）苯基）－６－（甲硫）四氫－２ｈ－哌喃－３，４，５－三醇的固體形態與其使用方法
|
|
SG2014012553A
(en)
|
2009-04-16 |
2014-05-29 |
Taisho Pharmaceutical Co Ltd |
Pharmaceutical compositions
|
|
PL2479165T3
(pl)
*
|
2009-09-16 |
2018-05-30 |
Astellas Pharma Inc. |
Związek glicynowy
|
|
EA020798B1
(ru)
|
2009-09-30 |
2015-01-30 |
Бёрингер Ингельхайм Интернациональ Гмбх |
СПОСОБ ПОЛУЧЕНИЯ КРИСТАЛЛИЧЕСКОЙ ФОРМЫ 1-ХЛОР-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГИДРОФУРАН-3-ИЛОКСИ)БЕНЗИЛ]БЕНЗОЛА
|
|
PT2486029E
(pt)
|
2009-09-30 |
2015-10-14 |
Boehringer Ingelheim Int |
Processos para a preparação de derivados de benzil-benzeno substituídos com glucopiranosilo
|
|
FI20115234A0
(fi)
|
2011-03-08 |
2011-03-08 |
Biotie Therapies Corp |
Uusia pyridatsinoni- ja pyridoniyhdisteitä
|
|
LT3002278T
(lt)
|
2011-03-15 |
2017-06-26 |
Astellas Pharma Inc. |
Guanidino junginys
|
|
AU2013255103B2
(en)
*
|
2012-05-02 |
2016-09-29 |
Syntara Limited |
Substituted 3-haloallylamine inhibitors of SSAO and uses thereof
|
|
CA2960280A1
(en)
|
2014-09-10 |
2016-03-17 |
Epizyme, Inc. |
Substituted piperidine compounds
|
|
AU2016301745B2
(en)
|
2015-08-06 |
2020-07-16 |
Ube Industries, Ltd. |
Substituted guanidine derivative
|
|
US10730850B2
(en)
|
2016-03-03 |
2020-08-04 |
Boehringer Ingelheim International Gmbh |
Pyridinylmethyl carbamimidoylcarbamate derivatives and their use as AOC3 inhibitors
|
|
EP3455216B1
(en)
|
2016-05-12 |
2020-11-04 |
Boehringer Ingelheim International GmbH |
Pyridinyl derivatives, pharmaceutical compositions and uses thereof as aoc3 inhibitors
|
|
WO2018027892A1
(en)
|
2016-08-12 |
2018-02-15 |
Eli Lilly And Company |
Amino pyrimidine ssao inhibitors
|
|
AU2018218521C1
(en)
|
2017-02-07 |
2022-06-09 |
Oblique Therapeutics Ab |
Heterocyclylsulfonyl-substituted pyridines and their use in the treatment of cancer
|
|
WO2018148856A1
(en)
*
|
2017-02-14 |
2018-08-23 |
Eli Lilly And Company |
Diazaspirodecanyl-pyrimidine compounds useful as ssao inhibitors
|
|
US20200087248A1
(en)
|
2017-04-28 |
2020-03-19 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Fluoroallylamine Derivative And Use Thereof
|
|
AU2018287777B2
(en)
|
2017-06-20 |
2020-05-21 |
Shandong Danhong Pharmaceutical Co., Ltd. |
SSAO inhibitor
|
|
CN109251166B
(zh)
|
2017-07-13 |
2021-11-05 |
广东东阳光药业有限公司 |
抑制ssao/vap-1的胺类化合物及其在医药上的应用
|
|
WO2019024924A1
(zh)
|
2017-08-04 |
2019-02-07 |
广东东阳光药业有限公司 |
抑制ssao/vap-1的胺类化合物及其在医药上的应用
|
|
CN109810041B
(zh)
|
2017-11-21 |
2023-08-15 |
药捷安康(南京)科技股份有限公司 |
卤代烯丙基胺类ssao/vap-1抑制剂及其应用
|
|
CN111989103A
(zh)
|
2018-04-17 |
2020-11-24 |
勃林格殷格翰国际有限公司 |
药物组合物、其治疗方法和用途
|
|
US12213970B2
(en)
|
2018-10-29 |
2025-02-04 |
Boehringer Ingelheim International Gmbh |
Pyridinyl sulfonamide derivatives, pharmaceutical compositions and uses thereof
|
|
KR102812426B1
(ko)
*
|
2018-10-29 |
2025-05-26 |
베링거 인겔하임 인터내셔날 게엠베하 |
피리디닐 설폰아미드 유도체, 약제학적 조성물 및 이의 용도
|